A novel eye-movement impairment in multiple sclerosis indicating widespread cortical damage

In multiple sclerosis, remyelination trials have yet to deliver success like that achieved for relapse rates with disease course modifying treatment trials. The challenge is to have a clinical, functional outcome measure. Currently, there are none that have been validated, other than visual evoked p...

Descripción completa

Detalles Bibliográficos
Autores principales: Nij Bijvank, Jenny A, Hof, Sam N, Prouskas, Stefanos E, Schoonheim, Menno M, Uitdehaag, Bernard M J, van Rijn, Laurentius J, Petzold, Axel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10232247/
https://www.ncbi.nlm.nih.gov/pubmed/36535900
http://dx.doi.org/10.1093/brain/awac474

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10232247/
https://www.ncbi.nlm.nih.gov/pubmed/36535900
http://dx.doi.org/10.1093/brain/awac474

Ejemplares similares